Patients in England with an incurable breast cancer can now access a life-extending drug on the NHS, two years after it was deemed too expensive by a health ...
The BBC understands that the drug companies Daiichi Sankyo and AstraZeneca have not substantially lowered their prices since the drug was first rejected.The ...